In COVID-19-mediated ischemic stroke, where the protective effects of ACE2 are downregulated or depleted due to the interaction between S protein and SARS-CoV-2, the balance is tilted in favor of ACE and angiotensin II. The gene discussed is ACE; the disease is ischemic stroke.